Home>Topics>Stocks>Roche Holding AG ADR

Roche Holding AG ADR RHHBY

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Cepheid's Results And Shares Are On Different Paths

      Headlines

      Tue, 22 Apr 2014

      molecular diagnostics segment of diagnostics, Cepheid ( CPHD ) remains one of the real up-and-comers. Roche ( OTCQX: RHHBY ) still has quite a bit more market share than Cepheid (and/or anybody else), but Cepheid stands shoulder to shoulder with

    2. Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff

      Headlines

      Mon, 21 Apr 2014

      By Sharon di Stefano : Cancer treatment's most prized goal has been and continues to be the selective death of tumor cells while keeping surrounding tissue unharmed. Chemotherapy does a fine job attacking malignancy, but drug molecules are so tiny they enter and poison healthy cells, the basis for

    3. Roche Reaffirms Full Year Outlook But Suffers From Currency Movements

      Headlines

      Wed, 16 Apr 2014

      By Trefis : Roche Holdings (OTC: RHHBY ) recently released its Q1 2014 results and reported a slight decline of 1% in its revenues. However, this decline is primarily

    4. Counterfeit Herceptin finds its way into European supply chain

      Headlines

      Wed, 16 Apr 2014

      Vials from nine batches of Roche's ( OTCQX: RHHBY ) top-selling drug allegedly stolen in Italy have been tampered with and reintroduced into the European market. Adulterated

    5. Roche's CEO Discusses Q1 2014 Results - Earnings Call Transcript

      Headlines

      Tue, 15 Apr 2014

      Roche Holding Ltd ADR ( OTCQX: RHHBY ) Q1 2014 Results Earnings Conference Call April 15, 2014 8:00 AM ET Executives Dr. Severin Schwan, Chief Executive Officer

    6. EMA finishes its examination of Roche

      Headlines

      Mon, 14 Apr 2014

      The European Medicines Agency concludes its inquiry into Roche's ( OTCQX: RHHBY +2% ) drug safety reporting. The firm allegedly under-reported adverse events for 19 of its drugs. It sends its findings

    7. Roche's Competitive Advantage

      Headlines

      Thu, 10 Apr 2014

      By Trefis : Roche Holdings ( OTCQX: RHHBY ) has managed to grow its revenues and earnings at an impressive rate, whereas other big pharmaceutical firms have suffered due

    8. Hospira wins U.K. patent suit

      Headlines

      Thu, 10 Apr 2014

      London's High Court rules Roche's ( OTCQX: RHHBY -0.7% ) 115 and 455 Herceptin patents are invalid paving the way for Hospira ( HSP -3.5% ) to market a biosimilar version

    9. French plan to allow generics alarms Big Pharma

      Headlines

      Thu, 10 Apr 2014

      generics. Substitutions only apply to retail pharmacies. 40% of biotech prescriptions are filled in hospitals. ( OTCQX: RHHBY ) ( AMGN ) ( NVS ) ( SNY ) ( LLY ) ( PFE ) ( BMY ) ( MRK ) ( GSK ) ( JNJ ) ( HSP ) ( ABBV ) ( AZN ) ( OTCPK:BAYRY ) Post your

    10. Research group says governments are wasting $ on flu drug stockpiles

      Headlines

      Thu, 10 Apr 2014

      from the research network the Cochrane Review doubt the wisdom of governments spending billions stockpiling Roche's ( OTCQX: RHHBY ) flu drug Tamiflu. Based on their review of the data, they conclude the only benefit is a half day reduction in flu symptoms

    « Prev12345Next »
    Content Partners